Geode Capital Management, LLC Co Diagnostics, Inc. Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 319,990 shares of CODX stock, worth $121,596. This represents 0.0% of its overall portfolio holdings.
Number of Shares
319,990
Previous 342,170
6.48%
Holding current value
$121,596
Previous $106,000
16.04%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding CODX
# of Institutions
38Shares Held
5.08MCall Options Held
65.5KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.73MShares$658,6330.0% of portfolio
-
Private Advisory Group LLC Redmond, WA1.18MShares$449,0200.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny561KShares$213,1880.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$190,7690.0% of portfolio
-
Jane Street Group, LLC New York, NY166KShares$63,1760.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $12.8M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...